Saturday, October 29, 2016 8:23:54 PM
1. We're going to learn of the first fiscal quarter's sales in about two weeks, presuming timely SEC reporting via 10Q. If the number exceeds $3 million and there is an operating profit before reckoning interest expense, that's bullish fundamentally. So we're not reliant upon a press release per se.
2. Maybe even more important would be the announcement that recapitalization is finally about to happen, as this has been in the air since May of last year. The company really ought to be providing progress reporting regarding this endeavor.
3. But I think the most bullish occurrence for the stock would be a Trump victory, given his platform on reducing regulatory burden (that means FDA in this case) particularly upon small businesses. The likelihood of Trump's winning has increased in the past couple of days, it would appear. (This is not a forum for politics, so I'm not commenting one way or the other about who's getting my vote, and I hope no subsequent poster will drag us further into anything political.)
Just on a personal note, if you should happen to sell and leave this board, your presence will be missed.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM